Roivant Sciences Ltd. (ROIV) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 19.22B |
| Enterprise Value | 17.9B |
| P/E Ratio | -96.84 |
| PEG Ratio | 0.81 |
| Price/Sales Ratio | 3,529.14 |
| Price/Book Ratio | 6.27 |
| Enterprise/Revenue | 3,377.61 |
| Enterprise/EBITDA | -88.63 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -35.35 |
| Operating Margin | -181.41 |
AD
Management Effectiveness
| Return On Assets | -0.05 |
| Return On Equity | -0.06 |
Income Statement
| Revenue | 8.26M |
| Revenue/Share | 0.01 |
| Gross Profit | 6.98M |
| EBITDA | -261.23M |
| Net Income | -299.77M |
| Diluted EPS | -0.43 |
Balance Sheet
| Total Cash | 3.84B |
| Total Cash/Share | 5.33 |
| Total Debt | 107.15M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 16.72 |
| Book Value Per Share | 6.83 |
Price History
| 52-Week Change | 105.93 |
| 52-Week High | 42.5 |
| 52-Week Low | 17.64 |
| Moving Average 50 Days | 36.61 |
| Moving Average 200 Days | 31 |
Statistics
| Average Volume | 7.25M |
| Shares Outstanding | 722.32M |
| % Held by Institutions | 77.77 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
